LATISSE solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.

The Origins Of LATISSE^®

 

The Story Behind The Discovery: 

Its remarkable how one great product can lead to another. Such was the case with LATISSE^®.

Allergan, a leader and pioneer in eye care, dermatology and medical aesthetics, has introduced the world to a range of products, including LATISSE^®, the first and only FDA-approved prescription treatment for inadequate or not enough eyelashes, growing them longer, fuller and darker. But its origin wasn’t completely new.

Back in 2001, Allergan developed a medicated eye drop used to treat ocular hypertension. In addition to successfully lowering eye pressure (the only treatable risk factor for glaucoma), many patients using this medication experienced a side effect — they began to grow longer, fuller and darker lashes.

This led Allergan to begin its study of this medication’s active ingredient, bimatoprost ophthalmic solution 0.03%, for the sole purpose of generating lash growth. After conducting a clinical trial on safety and efficacy for 4 months on 278 patients, LATISSE^® earned its FDA approval in December 2008. Since then, Allergan has sold approximately 1.5 million bottles of LATISSE^® solution.

For an appointment to evaluate your lashes and to find out if LATISSE is right for you, please call (410)571-1280.